Jpmorgan Chase & CO Tenaya Therapeutics, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TNYA
# of Institutions
99Shares Held
56.1MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$22.7 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$18.4 Million0.36% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$16.2 Million1.8% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$9.82 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$8.47 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $99.7M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...